This inventor holds 4 USPTO granted patents and 12 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Ikfe Institut Fur Klinische Forschung Und Entwicklung Gmbh, Becton Dickinson and Company Limited, Other. Active years: 2012-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2012-2020
Title: The Innovations of Andreas Pfuetzner
Introduction
Andreas Pfuetzner is a notable inventor based in Mainz, Germany. He has made significant contributions to the field of medical research, particularly in the area of diabetes and metabolic syndrome. With a total of 4 patents to his name, Pfuetzner's work focuses on innovative methods for diagnosing and treating insulin resistance.
Latest Patents
Pfuetzner's latest patents include a method of treating vascular insulin resistance in a normoglycemic subject based on biomarkers. This invention provides compositions and methods for determining insulin resistance and/or pancreatic β-cell dysfunction in a subject. Additionally, it offers compositions and methods for treating a subject according to the insulin resistance and/or pancreatic β-cell dysfunction identified. Another significant patent is a method and system for measuring a sample to determine the presence of and optionally treat a pathologic condition. This invention provides diagnostic in vitro methods, as well as kits and devices, for the diagnosis or prognosis of a pathologic condition characterized by the presence or absence of an endogenous hormone and/or hormone analogs involved in diabetes or metabolic syndrome.
Career Highlights
Throughout his career, Pfuetzner has worked with various organizations, including the Ikfe Institut für Klinische Forschung und Entwicklung GmbH. His work has been instrumental in advancing the understanding and treatment of metabolic disorders.
Collaborations
Pfuetzner has collaborated with notable professionals in his field, including Thomas Forst and Mikkel Nissum. These collaborations have further enriched his research and innovations.
Conclusion
Andreas Pfuetzner's contributions to medical research through his patents and collaborations highlight his commitment to improving health outcomes for individuals with insulin resistance and metabolic syndrome. His innovative approaches continue to pave the way for advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile